Literature DB >> 31734646

Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.

Donghong He1, Amy W Lasek2.   

Abstract

The dopamine D2 receptor (D2R) is a G protein-coupled receptor (GPCR) expressed in regions of the brain that control motor function, cognition, and motivation. As a result, D2R is involved in the pathophysiology of disorders such as schizophrenia and drug addiction. Understanding the signaling pathways activated by D2R is crucial to finding new therapeutic targets for these disorders. D2R stimulation by its agonist, dopamine, causes desensitization and internalization of the receptor. A previous study found that inhibitors of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) blocked D2R desensitization in neurons in the ventral tegmental area of the brain. In the present study, using a cell-based system, we investigated whether ALK regulates D2R internalization. The ALK inhibitor alectinib completely inhibited dopamine-induced D2R internalization. Since GPCRs can transactivate receptor tyrosine kinases, we also examined if D2R stimulation activated ALK signaling. ALK phosphorylation increased by almost 2-fold after dopamine treatment and ALK coimmunoprecipitated with D2R. To identify the signaling pathways downstream of ALK that might regulate D2R internalization, we used pharmacological inhibitors of proteins activated by ALK signaling. Protein kinase Cγ was activated by dopamine in an ALK-dependent manner, and a protein kinase C inhibitor completely blocked dopamine-induced D2R internalization. Taken together, these results identify ALK as a receptor tyrosine kinase transactivated by D2R that promotes its internalization, possibly through activation of protein kinase C. ALK inhibitors could be useful in enhancing D2R signaling. SIGNIFICANCE STATEMENT: Receptor internalization is a mechanism by which receptors are desensitized. In this study we found that agonist-induced internalization of the dopamine D2 receptor is regulated by the receptor tyrosine kinase ALK. ALK was also transactivated by and associated with dopamine D2 receptor. Dopamine activated protein kinase C in an ALK-dependent manner and a PKC inhibitor blocked dopamine D2 receptor internalization. These results indicate that ALK regulates dopamine D2 receptor trafficking, which has implications for psychiatric disorders involving dysregulated dopamine signaling.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31734646      PMCID: PMC6964149          DOI: 10.1124/mol.119.117473

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  46 in total

1.  D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions.

Authors:  Jeremy Celver; Meenakshi Sharma; Abraham Kovoor
Journal:  J Neurochem       Date:  2011-11-24       Impact factor: 5.372

2.  Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism.

Authors:  Dominic Thibault; Paul R Albert; Graciela Pineyro; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

3.  Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.

Authors:  Christel Moog-Lutz; Joffrey Degoutin; Jean Y Gouzi; Yvelyne Frobert; Nicole Brunet-de Carvalho; Jocelyne Bureau; Christophe Créminon; Marc Vigny
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

4.  Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.

Authors:  T Iwahara; J Fujimoto; D Wen; R Cupples; N Bucay; T Arakawa; S Mori; B Ratzkin; T Yamamoto
Journal:  Oncogene       Date:  1997-01-30       Impact factor: 9.867

5.  Plasma membrane compartmentalization of D2 dopamine receptors.

Authors:  Meenakshi Sharma; Jeremy Celver; J Christopher Octeau; Abraham Kovoor
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

6.  Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.

Authors:  Isabelle Janoueix-Lerosey; Delphine Lequin; Laurence Brugières; Agnès Ribeiro; Loïc de Pontual; Valérie Combaret; Virginie Raynal; Alain Puisieux; Gudrun Schleiermacher; Gaëlle Pierron; Dominique Valteau-Couanet; Thierry Frebourg; Jean Michon; Stanislas Lyonnet; Jeanne Amiel; Olivier Delattre
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

7.  An evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanol.

Authors:  Amy W Lasek; Jana Lim; Christopher L Kliethermes; Karen H Berger; Geoff Joslyn; Gerry Brush; Liquan Xue; Margaret Robertson; Monica S Moore; Karen Vranizan; Stephan W Morris; Marc A Schuckit; Raymond L White; Ulrike Heberlein
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

8.  Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes.

Authors:  R G Vickery; M von Zastrow
Journal:  J Cell Biol       Date:  1999-01-11       Impact factor: 10.539

9.  Role for Rab10 in Methamphetamine-Induced Behavior.

Authors:  Scott M Vanderwerf; David C Buck; Phillip A Wilmarth; Leila M Sears; Larry L David; David B Morton; Kim A Neve
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

10.  Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts.

Authors:  Juan Palacios-Moreno; Lauren Foltz; Ailan Guo; Matthew P Stokes; Emily D Kuehn; Lynn George; Michael Comb; Mark L Grimes
Journal:  PLoS Comput Biol       Date:  2015-04-17       Impact factor: 4.475

View more
  2 in total

Review 1.  Mechanisms of selective G protein-coupled receptor localization and trafficking.

Authors:  Jennifer M Kunselman; Joshua Lott; Manojkumar A Puthenveedu
Journal:  Curr Opin Cell Biol       Date:  2021-05-07       Impact factor: 8.386

2.  Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.

Authors:  Monia Sisi; Michele Fusaroli; Andrea De Giglio; Francesco Facchinetti; Andrea Ardizzoni; Emanuel Raschi; Francesco Gelsomino
Journal:  Target Oncol       Date:  2022-01-13       Impact factor: 4.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.